Prospective comparison of subcutaneous to intravenous administration of bortezomib in patients with multiple myeloma: Pharmacokinetics, efficacy and toxicity

被引：0
作者：
Moreau, P.
Coiteux, V.
Hulin, C.
Facon, T.
van de Velde, H.
Acharya, M.
Harousseau, J.
机构：
[1] CHU Hotel Dieu, Nantes, France
[2] Univ Hosp, Lille, France
[3] Univ Hosp, Nancy, France
[4] Johnson & Jonhson, R&D, Beerse, Belgium
[5] Johnson & Jonhson, R&D, Raritan, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8046
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Subcutaneous Administration of Bortezomib in Combination with Thalidomide and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma Patients
    Wu, Shenghao
    Zheng, Cuiping
    Chen, Songyan
    Cai, Xiaoping
    Shi, Yuejian
    Lin, Bijing
    Chen, Yuemiao
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [32] Intravenous (IV) bortezomib infusion after non-response to subcutaneous bortezomib administration can induce transitory responses in multiple myeloma patients: are some patients more sensitive to IV bortezomib?
    Gozzetti, Alessandro
    Candi, Veronica
    Brambilla, Corrado Zuanelli
    Papini, Giulia
    Bocchia, Monica
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 177 (01) : 144 - 147
  • [33] Efficacy and toxicity of contemporary intravenous treatment with Bortezomib, Melphalan and Dexamethasone in previously treated myeloma patients
    Di Raimondo, F.
    Chiarenza, A.
    Del, Fabbro, V
    Schinocca, L.
    Fiumara, P.
    Palumbo, G. A.
    Conticello, C.
    Moschetti, G.
    Giustolisi, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 145 - 145
  • [34] Impact of Switching from Intravenous to Subcutaneous Bortezomib in Real Life. Overlapping Toxicity and Efficacy in All Settings of Myeloma Patients Balancing Schedule and Way of Bortezomib Adminisration
    Mangiacavalli, Silvia
    Cocito, Federica
    Ferretti, Virginia Valeria
    Cartia, Claudio Salvatore
    Ganzetti, Maya
    Cazzola, Mario
    Corso, Alessandro
    BLOOD, 2016, 128 (22)
  • [35] Subcutaneous and Intravenous Bortezomib in Multiple Myeloma Patients Has Similar Response Rates and Toxicity Profile with No Difference in the Incidence of Peripheral Neuropathy: Report of the Czech Myeloma Group
    Minarik, Jiri
    Pavlicek, Petr
    Pour, Ludek
    Pika, Tomas
    Maisnar, Vladimir
    Spicka, Ivan
    Jarkovsky, Jiri
    Krejci, Marta
    Bacovsky, Jaroslav
    Radocha, Jakub
    Straub, Jan
    Kessler, Petr
    Wrobel, Marek
    Walterova, Lenka
    Sykora, Michal
    Obernauerova, Jarmila
    Gregora, Evzen
    Adamova, Dagmar
    Gumulec, Jaromir
    Adam, Zdenek
    Scudla, Vlastimil
    Hajek, Roman
    BLOOD, 2014, 124 (21)
  • [36] EFFICACY AND SAFETY OF THREE SUBCUTANEOUS BORTEZOMIB COMBINATIONS IN ELDERLY, NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
    Cerrato, C.
    Oliva, S.
    Petrucci, M. T.
    Caraffa, P.
    Nozzoli, C.
    Finsinger, P.
    Larocca, A.
    De Rosa, L.
    De Paoli, L.
    Montefusco, V.
    Saraci, E.
    Villani, O.
    Carella, A. M.
    Benevolo, G.
    Morabito, F.
    Liberati, A. M.
    Derudas, D.
    Boccadoro, M.
    Sonneveld, P.
    Palumbo, A.
    HAEMATOLOGICA, 2014, 99 : 107 - 107
  • [37] SUBCUTANEOUS BORTEZOMIB IN PATIENTS OVER 75 YEARS WITH MULTIPLE MYELOMA
    Violeta, Martinez-Robles
    Belen, Ballina
    Seila, Cerda
    Filomeno, Rondon
    Natalia, De Las Heras
    Jose-Antonio, Rodriguez-Garcia
    Fernando, Escalante
    HAEMATOLOGICA, 2016, 101 : 302 - 302
  • [38] IRON ADMINISTRATION INCREASES BORTEZOMIB EFFICACY IN MULTIPLE MYELOMA MURINE MODELS
    Bordini, Jessica
    Morisi, Federica
    Fulli, Alessia
    Venturi, Gianluca
    Camaschella, Clara
    Campanella, Alessandro
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (08) : E398 - E398
  • [39] Pharmacokinetics of Trastuzumab After Subcutaneous and Intravenous Administration in Obese Patients
    Gonzalez Garcia, Jonathan
    Gutierrez Nicolas, Fernando
    Ramos Diaz, Ruth
    Nazco Casariego, Gloria Julia
    Vina Romero, Maria Micaela
    Llabres Martinez, Matias
    Llanos Munoz, Marta
    Batista Lopez, Jose Norberto
    Jimenez Sosa, Alejandro
    Ceballos Lenza, Isaac
    Cruz Jurado, Josefina
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (08) : 775 - 779
  • [40] Clinical Risk Factors for Peripheral Neuropathy in Patients Treated with Subcutaneous or Intravenous Bortezomib for Newly Diagnosed Multiple Myeloma
    Merz, Maximillan
    Salwender, Hans-Juergen
    Haenel, Mathias
    Bertsch, Uta
    Kunz, Christina
    Hielscher, Thomas
    Blau, Igor W.
    Scheid, Christof
    Mai, Elias Karl
    Hose, Dirk
    Schurich, Baerbel
    Munder, Markus
    Brossart, Peter
    Gerecke, Christian
    Lindemann, Hans Walter
    Zeis, Matthias
    Weisel, Katja C.
    Duerig, Jan
    Goldschmidt, Hartmut
    BLOOD, 2015, 126 (23)
12345